Behavioral preclinical models of anxiety;Behaviorální preklinické modely úzkosti

Psychiatrie

Volumn 8, Issue 1, 2004, Pages 31-35

  Votava, Martin ^a   Uhlířová, Leona ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anxiety; Anxiety tests; Behavior; Benzodiazepines; SSRI

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BUSPIRONE; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; MEPROBAMATE; NEUROSTEROID; PAROXETINE; PROMAZINE; SEROTONIN 2A AGONIST; SEROTONIN UPTAKE INHIBITOR; TROPISETRON;

ANIMAL MODEL; ANXIETY DISORDER; BEHAVIOR; DRUG EFFICACY; GENERALIZED ANXIETY DISORDER; HUMAN; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREDATION; PSYCHOPHARMACOTHERAPY; REVIEW; SOCIAL INTERACTION; SOCIAL PHOBIA;

EID: 1842713057     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Blanchard DC, Griebel G, Blanchard RJ. The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol 2003;463:97-116.
2. Blanchard RJ, Blanchard DC. Crouching as an index of fear. J Comp Physiol Psychol 1969;67:370-375.
3. Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) 1989;97:277-279.
4. Borsini F, Lecci A, Volterra G, Meli A. A model to measure anticipatory anxiety in mice? Psychopharmacology (Berl) 1989;98:207-211.
5. Borsini F, Podhorna J, Marazziti D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 2002;163:121-141.
6. Bourin M, Hascoet M. The mouse light/dark box test. Eur J Pharmacol 2003;463:55-65.
7. Bristow LJ, O'Connor D, Watts R, Duxon MS, Hutson PH. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat. Neuropharmacology 2000;39:1222-1236.
8. Burgdorf J, Knutson B, Panksepp J, Shippenberg TS. Evaluation of rat ultrasonic vocalizations as predictors of the conditioned aversive effects of drugs. Psychopharmacology (Berl) 2001;155:35-42.
9. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980;13:167-170.
10. Cutler MG, Rodgers RJ, Jackson JE. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine. I. Social interactions. Pharmacol Biochem Behav 1997;57:119-125.
11. Davis M. Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology (Berl) 1979;62:1-7.
12. De Boer SF, Koolhaas JM. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 2003;463:145-161.
13. Duxon MS, Starr KR, Upton N. Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635. Br J Pharmacol 2000;130:1713-1719.
14. File SE, Ouagazzal AM, Gonzalez LE, Overstreet DH. Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function. Pharmacol Biochem Behav 62:1999;695-701.
15. File SE, Seth P. A review of 25 years of the social interaction test. Eur J Pharmacol 2003;463:35-53.
16. Geller I, Seifter J. The effects of meprobamate, barbiturate, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1960;482-492.
17. Goa KL, Ward A. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 1986;32:114-129.
18. Griebel G, Blanchard DC, Agnes RS, Blanchard RJ. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology (Berl) 1995;120:57-66.
19. Hall CS. Emotional behavior in the rat: I. Defecation and urination as measures of individual differences in emotionality. J Comp Physiol Psychol 1934;18:385-403.
20. Ichimaru Y, Egawa T, Sawa A. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 1995;68:65-70.
21. Kramer MS, Cutler NR, Ballenger JC, Patterson WM, Mendels J, Chenault A, Shrivastava R, Matzura-Wolfe D, Lines C and Reines S. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry 1995;37:462-466.
22. Krsiak M. Timid singly-housed mice: their value in prediction of psychotropic activity of drugs. Br J Pharmacol 1975;55:141-150.
23. Krsiak M. Effects of drugs on behaviour of aggressive mice. Br J Pharmacol 1979;65:525-533.
24. Krsiak M, Sulcova A. Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice. Psychopharmacology (Berl) 1990;101:396-402.
25. Lecrubier Y, Puech AJ, Azcona A, Bailey PE, Lataste X. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology (Berl) 1993;112:129-133.
26. Lightowler S, Kennett GA, Williamson IJ, Blackburn TP, Tulloch IF. Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol Biochem Behav 1994;49:281-285.
27. Merali Z, Levac C, Anisman H. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 2003;54:552-565.
28. Millan MJ, Brocco M. The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines. Eur J Pharmacol 2003;463:67-96.
29. Olivier B, Zethof T, Pattij T, van Boogaert M, van Oorschot R, Leahy C, Oosting R, Bouwknecht A, Veening J, van der GJ, Groenink L. Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 2003;463:117-132.
30. Patel JB, Migler B. A sensitive and selective monkey conflict test. Pharmacol Biochem Behav 1982;17:645-649.
31. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14:149-167.
32. Pinel JPJ, Treit D. Burying as a defensive response in rats. J Comp Physiol Psychol 1978;92:708-712.
33. Podhorna J, Krsiak M. Behavioural effects of a benzodiazepine receptor partial agonist, Ro 19-8022, in the social conflict test in mice. Behav Pharmacol 2000;11:143-151.
34. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003;463:3-33.
35. Sanchez C. Stress-induced vocalisation in adult animals. A valid model of anxiety? Eur J Pharmacol 2003;463:133-143.
36. Taylor DP, Moon SL. Buspirone and related compounds as alternative anxiolytics. Neuropeptides 19 1991;Suppl:15-19.
37. To CT, Anheuer ZE, Bagdy G. Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety. Neuroreport 1999;10:553-555.
38. Tonoue T, Ashida Y, Makino H, Hata H. Inhibition of shock-elicited ultrasonic vocalization by opioid peptides in the rat: a psychotropic effect. Psychoneuroendocrinology 1986;11:177-184.
39. Uhlirova L, Sustkova-Fiserova M, Krsiak M. Behavioral effects of flumazenil in the social conflict test in mice. Psychopharmacology (Berl) 2003.
40. Vogel JR, Beer B, Clody DE. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 1971;21:1-7.